Oneness Biotech Co., Ltd. (LUX:ONEA)

Oneness Biotech Statistics

Total Valuation

Oneness Biotech has a market cap or net worth of EUR 926.39 million. The enterprise value is 788.46 million.

Market Cap	926.39M
Enterprise Value	788.46M

Important Dates

The last earnings date was Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.31%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	8.17%
Owned by Institutions (%)	6.42%
Float	304.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	282.41
PB Ratio	3.02
P/TBV Ratio	3.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-20.10
EV / Sales	244.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-58.47

Financial Position

The company has a current ratio of 37.04, with a Debt / Equity ratio of 0.04.

Current Ratio	37.04
Quick Ratio	35.83
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.81
Interest Coverage	-92.50

Financial Efficiency

Return on equity (ROE) is -11.42% and return on invested capital (ROIC) is -4.16%.

Return on Equity (ROE)	-11.42%
Return on Assets (ROA)	-4.02%
Return on Invested Capital (ROIC)	-4.16%
Return on Capital Employed (ROCE)	-7.22%
Revenue Per Employee	76,287
Profits Per Employee	-912,025
Employee Count	43
Asset Turnover	0.01
Inventory Turnover	0.74

Taxes

In the past 12 months, Oneness Biotech has paid 52,283 in taxes.

Income Tax	52,283
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.68% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.68%
50-Day Moving Average	10.41
200-Day Moving Average	10.80
Relative Strength Index (RSI)	61.99
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Oneness Biotech had revenue of EUR 3.28 million and -39.22 million in losses. Loss per share was -0.08.

Revenue	3.28M
Gross Profit	862,673
Operating Income	-23.55M
Pretax Income	-39.05M
Net Income	-39.22M
EBITDA	-15.00M
EBIT	-23.55M
Loss Per Share	-0.08

Balance Sheet

The company has 164.61 million in cash and 10.87 million in debt, giving a net cash position of 153.75 million.

Cash & Cash Equivalents	164.61M
Total Debt	10.87M
Net Cash	153.75M
Net Cash Per Share	n/a
Equity (Book Value)	306.60M
Book Value Per Share	0.61
Working Capital	169.10M

Cash Flow

In the last 12 months, operating cash flow was -12.66 million and capital expenditures -826,270, giving a free cash flow of -13.49 million.

Operating Cash Flow	-12.66M
Capital Expenditures	-826,270
Free Cash Flow	-13.49M
FCF Per Share	n/a

Margins

Gross Margin	26.30%
Operating Margin	-718.06%
Pretax Margin	-1,190.58%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Oneness Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.31%
Shareholder Yield	-0.31%
Earnings Yield	-4.23%
FCF Yield	-1.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Oneness Biotech has an Altman Z-Score of 26.61 and a Piotroski F-Score of 2.

Altman Z-Score	26.61
Piotroski F-Score	2